Therapeutic issues in HIV/HCV-coinfected patients
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients
Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis
Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin
Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users
No significant differences in histology and response to interferon treatment in hepatitis B carriers of genotypes C and recombinant B
Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China*
Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections